These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30033768)

  • 1. Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy.
    Hemati M; Haghiralsadat F; Yazdian F; Jafari F; Moradi A; Malekpour-Dehkordi Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1295-1311. PubMed ID: 30033768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes.
    Hemati M; Haghiralsadat F; Jafary F; Moosavizadeh S; Moradi A
    Int J Nanomedicine; 2019; 14():6575-6585. PubMed ID: 31616144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance.
    Haghiralsadat F; Amoabediny G; Naderinezhad S; Zandieh-Doulabi B; Forouzanfar T; Helder MN
    Int J Nanomedicine; 2018; 13():3853-3866. PubMed ID: 30013340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
    J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes.
    Luo D; Geng J; Li N; Carter KA; Shao S; Atilla-Gokcumen GE; Lovell JF
    Mol Cancer Ther; 2017 Nov; 16(11):2452-2461. PubMed ID: 28729400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new formulation of hydrophobin-coated niosome as a drug carrier to cancer cells.
    Barani M; Mirzaei M; Torkzadeh-Mahani M; Lohrasbi-Nejad A; Nematollahi MH
    Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110975. PubMed ID: 32487392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of miRNA-15a and miRNA-16-1 using cationic PEGylated niosomes downregulates Bcl-2 and induces apoptosis in prostate cancer cells.
    Ghaffari M; Kalantar SM; Hemati M; Dehghani Firoozabadi A; Asri A; Shams A; Jafari Ghalekohneh S; Haghiralsadat F
    Biotechnol Lett; 2021 May; 43(5):981-994. PubMed ID: 33515341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound.
    Endo-Takahashi Y; Negishi Y; Kato Y; Suzuki R; Maruyama K; Aramaki Y
    Int J Pharm; 2012 Jan; 422(1-2):504-9. PubMed ID: 22119963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of mono- and multi-hydroxyl low toxicity pH-sensitive cationic lipids for drug delivery.
    Zhao Z; Yao W; Wang N; Liu C; Zhou H; Chen H; Qiao W
    Eur J Pharm Sci; 2019 May; 133():69-78. PubMed ID: 30914360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.
    Li H; Hao Y; Wang N; Wang L; Jia S; Wang Y; Yang L; Zhang Y; Zhang Z
    Drug Deliv; 2016; 23(3):840-8. PubMed ID: 24892622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface modified niosomal quercetin with cationic lipid: an appropriate drug delivery system against Pseudomonas aeruginosa Infections.
    Hemmati J; Chiani M; Chegini Z; Seifalian A; Arabestani MR
    Sci Rep; 2024 Jun; 14(1):13362. PubMed ID: 38862754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance.
    Yu J; Chen H; Jiang L; Wang J; Dai J; Wang J
    J Pharm Sci; 2019 May; 108(5):1788-1799. PubMed ID: 30610857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-decorated PEGylated triblock copolymer as a pH/reduction dual-responsive nanovehicle for targeted intracellular co-delivery of doxorubicin and Bcl-2 siRNA.
    Suo A; Qian J; Xu M; Xu W; Zhang Y; Yao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():659-672. PubMed ID: 28482576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
    Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
    Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
    Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
    Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Box Behnken design of siRNA-loaded liposomes for the treatment of a murine model of ocular keratitis caused by Acanthamoeba.
    Zorzi GK; Schuh RS; Maschio VJ; Brazil NT; Rott MB; Teixeira HF
    Colloids Surf B Biointerfaces; 2019 Jan; 173():725-732. PubMed ID: 30384269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
    Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T
    Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier.
    Yuan BO; Zhao Y; Dong S; Sun Y; Hao F; Xie J; Teng L; Lee RJ; Fu Y; Bi YE
    Anticancer Res; 2019 Jan; 39(1):237-243. PubMed ID: 30591464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.